MILD hypoglycaemic reactions are well recognized as a complication of chlorpropamide therapy, and have been estimated as occurring in 7% of all cases (Stowers & Bewsher, 1962) . Severe hypoglycaemic coma due to this drug seems, however, to have been infrequently recognized, and we have been able to find only four isolated reports of this condition in the literature (Coates & Robbins, 1959; Bloch & Lenhardt, 1959; Sackner & Balian, 1960; Lindeman, 1960 (Sackner & Balian, 1960) The recurrence of severe hypoglycaemia within 48 hr of the initial episode compares with previously reported cases, and is a feature that should always be expected in these patients.
In considering the factors responsible for the prolonged hypoglycaemia, a brief mention of the pharmacology of chlorpropamide is relevant. The drug is rapidly absorbed from the gastro-intestinal tract; in the serum it is bound to protein, and the half-life in the plasma has been estimated at 33 hr. It is excreted by the kidney and 70-80% of 35S-labelled chlorpropamide has been found unchanged in the urine after 72 hr (Johnson et al., 1959 (Jarrett & Butterfield, 1964 ). We have not studied leucine tolerance in our patients, but a careful history has not revealed any change in their dietary intake in the period preceding the hypoglycaemic episode, and it seems unlikely that this mechanism was of much significance in the present series.
Failure of compensatory release of glucose from the liver may be responsible for prolonged hypoglycaemia. Reduced Failure of renal excretion of the sulphonylureas has been suggested as a cause of protracted hypoglycaemia (Bolinger, Tu & Kendall, 1960 
